Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
1 other identifier
observational
12
1 country
1
Brief Summary
To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer for female patients compared to male patients. The outcome of the study is to prospectively assess both subjective and objective gender disparities in voice and speech outcomes of patients using TEP after total laryngectomy across a multiple institutions. The investigators hypothesize that both subjective and objective measurements of voice, speech and quality of life will be poorer for female patients in comparison to male patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 5, 2022
CompletedStudy Start
First participant enrolled
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
February 11, 2026
February 1, 2026
3 years
July 28, 2022
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
FACT-H&N (Functional Assessment of Cancer Therapy - Head & Neck)
Patient reported survey.
Through study completion; 3 years (anticipate completion by June 2025)
AVHI (Alaryngeal Voice Handicap Index)
Patient reported survey.
Through study completion; 3 years (anticipate completion by June 2025)
Secondary Outcomes (3)
GRBAS - Grade, Roughness, Breathiness, Asthenia, and Strain
Through study completion; 3 years (anticipate completion by June 2025)
Sustained phonation time
Through study completion; 3 years (anticipate completion by June 2025)
Fundamental frequency
Through study completion; 3 years (anticipate completion by June 2025)
Eligibility Criteria
patients with advanced laryngeal cancer who have completed total laryngectomy requiring use of alternative methods to produce voice along with extensive speech rehabilitation.
You may qualify if:
- Male and female subjects who have completed total laryngectomy and are using TEP
You may not qualify if:
- Subjects who have not completed total laryngectomy and are not using TEP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Diego
La Jolla, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2022
First Posted
August 5, 2022
Study Start
May 31, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
February 11, 2026
Record last verified: 2026-02